Skip to main content
Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
9.36
0.00 (0.00%)
Apr 17, 2025, 4:00 PM EDT

Extendicare Revenue

In the year 2024, Extendicare had annual revenue of 1.47B CAD with 12.36% growth. Extendicare had revenue of 391.56M in the quarter ending December 31, 2024, with 11.82% growth.

Revenue
1.47B CAD
Revenue Growth
+12.36%
P/S Ratio
0.78
Revenue / Employee
62.39K CAD
Employees
23,500
Market Cap
797.14M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.47B161.25M12.36%
Dec 31, 20231.30B83.38M6.83%
Dec 31, 20221.22B54.59M4.68%
Dec 31, 20211.17B63.44M5.75%
Dec 31, 20201.10B-28.41M-2.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Northwest Biotherapeutics 1.38M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
BioStem Technologies 210.49M
American Oncology Network 1.76B
Revenue Rankings

Extendicare News

More News